DT Investment Partners’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.49K Hold
168
﹤0.01% 392
2025
Q4
$9.98K Hold
168
﹤0.01% 415
2025
Q3
$9.1K Hold
168
﹤0.01% 417
2025
Q2
$9.23K Hold
168
﹤0.01% 413
2025
Q1
$11.9K Hold
168
﹤0.01% 378
2024
Q4
$11K Sell
168
-55
-25% -$3.68K ﹤0.01% 399
2024
Q3
$15.7K Buy
223
+55
+33% +$4.6K ﹤0.01% 389
2024
Q2
$13.8K Sell
168
-63
-27% -$5.25K ﹤0.01% 349
2024
Q1
$20.2K Hold
231
﹤0.01% 286
2023
Q4
$20.7K Hold
231
﹤0.01% 275
2023
Q3
$20.4K Hold
231
﹤0.01% 259
2023
Q2
$20.6K Hold
231
﹤0.01% 265
2023
Q1
$22.4K Hold
231
﹤0.01% 258
2022
Q4
$23.9K Hold
231
﹤0.01% 251
2022
Q3
$20K Buy
+231
New +$20.6K ﹤0.01% 250

Other funds holding BMRN